<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ana Gonz√°lez-Angulo - Targeted Cancer Drug Delivery Pioneer | Heroes of Innovation</title>
    <meta name="description" content="Discover Ana Gonz√°lez-Angulo, the Mexican oncologist who developed revolutionary targeted cancer drug delivery systems using nanoparticles, reducing chemotherapy side effects and saving lives.">
    <meta name="keywords" content="Ana Gonz√°lez-Angulo, cancer treatment, targeted drug delivery, nanomedicine, oncology, chemotherapy, Mexican scientist, MD Anderson Cancer Center">
    <meta name="author" content="Heroes of Innovation">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://www.americaninventions.org/inventor/ana-gonzalez-angulo.html">
    <meta property="og:title" content="Ana Gonz√°lez-Angulo - Targeted Cancer Drug Delivery Pioneer">
    <meta property="og:description" content="Mexican oncologist who developed nanoparticle technology to target cancer cells while sparing healthy tissue.">
    <meta property="og:image" content="https://www.americaninventions.org/og-image.jpg">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://www.americaninventions.org/inventor/ana-gonzalez-angulo.html">
    <meta property="twitter:title" content="Ana Gonz√°lez-Angulo - Cancer Treatment Innovator">
    <meta property="twitter:description" content="Revolutionizing cancer treatment with targeted nanoparticle drug delivery.">
    <meta property="twitter:image" content="https://www.americaninventions.org/og-image.jpg">

    <!-- Canonical URL -->
    <link rel="canonical" href="https://www.americaninventions.org/inventor/ana-gonzalez-angulo.html">

    <!-- Favicon -->
    <link rel="icon" href="data:image/svg+xml,<svg xmlns=%22http://www.w3.org/2000/svg%22 viewBox=%220 0 100 100%22><text y=%22.9em%22 font-size=%2290%22>üí°</text></svg>">

    <!-- Structured Data -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "Person",
      "name": "Ana Mar√≠a Gonz√°lez-Angulo",
      "birthDate": "1968",
      "nationality": "Mexican",
      "jobTitle": "Oncologist and Medical Researcher",
      "knowsAbout": ["Oncology", "Targeted Drug Delivery", "Nanomedicine", "Cancer Research"],
      "description": "Mexican oncologist who developed revolutionary targeted cancer drug delivery systems using nanoparticles, reducing chemotherapy side effects and improving treatment outcomes.",
      "alumniOf": "MD Anderson Cancer Center"
    }
    </script>

    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What did Ana Gonz√°lez-Angulo invent?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Ana Gonz√°lez-Angulo developed a targeted cancer drug delivery system using nanoparticles that can identify and attack cancer cells while leaving healthy cells unharmed. This technology significantly reduces chemotherapy side effects and improves treatment effectiveness."
          }
        },
        {
          "@type": "Question",
          "name": "How does targeted drug delivery help cancer patients?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Targeted drug delivery systems like Gonz√°lez-Angulo's use nanoparticles to deliver chemotherapy drugs directly to cancer cells, minimizing damage to healthy tissue. This approach reduces side effects like nausea, hair loss, and organ damage while improving treatment effectiveness and patient survival rates."
          }
        },
        {
          "@type": "Question",
          "name": "What is nanomedicine?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Nanomedicine uses extremely small particles (nanoparticles) to deliver drugs, diagnose diseases, or repair damaged tissue at the molecular level. Gonz√°lez-Angulo's work uses nanoparticles engineered to recognize cancer cells and deliver chemotherapy drugs specifically to tumors."
          }
        }
      ]
    }
    </script>

    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Georgia', serif;
            line-height: 1.8;
            color: #1a1a1a;
            background: #ffffff;
        }

        .top-nav {
            background: #000000;
            padding: 1rem 0;
            position: sticky;
            top: 0;
            z-index: 1000;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }

        .nav-container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 20px;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .nav-logo {
            color: #ffffff;
            text-decoration: none;
            font-size: 1.2rem;
            font-weight: 700;
        }

        .nav-links a {
            color: #ffffff;
            text-decoration: none;
            margin-left: 2rem;
            transition: opacity 0.3s;
        }

        .nav-links a:hover {
            opacity: 0.7;
        }

        .hero {
            background: linear-gradient(135deg, #e056fd 0%, #686de0 100%);
            color: #ffffff;
            padding: 4rem 0;
            text-align: center;
        }

        .hero-content {
            max-width: 900px;
            margin: 0 auto;
            padding: 0 20px;
        }

        .inventor-emoji {
            font-size: 5rem;
            margin-bottom: 1rem;
            display: block;
        }

        h1 {
            font-size: clamp(2rem, 5vw, 3.5rem);
            margin-bottom: 1rem;
            font-weight: 700;
        }

        .hero-subtitle {
            font-size: 1.3rem;
            opacity: 0.95;
            margin-bottom: 1rem;
        }

        .hero-dates {
            font-size: 1.1rem;
            opacity: 0.85;
            font-style: italic;
        }

        .hero-flag {
            font-size: 2rem;
            margin-top: 1rem;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            padding: 3rem 20px;
        }

        .quick-facts {
            background: #f8f9fa;
            border-left: 4px solid #686de0;
            padding: 2rem;
            margin: 2rem 0;
            border-radius: 8px;
        }

        .quick-facts h2 {
            font-size: 1.5rem;
            margin-bottom: 1rem;
            color: #686de0;
        }

        .fact-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
            margin-top: 1.5rem;
        }

        .fact-item {
            padding: 1rem;
            background: #ffffff;
            border-radius: 6px;
        }

        .fact-label {
            font-weight: 700;
            color: #e056fd;
            margin-bottom: 0.5rem;
            font-size: 0.9rem;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .fact-value {
            font-size: 1.1rem;
            color: #1a1a1a;
        }

        section {
            margin: 3rem 0;
        }

        h2 {
            font-size: 2rem;
            margin-bottom: 1.5rem;
            color: #1a1a1a;
            border-bottom: 3px solid #686de0;
            padding-bottom: 0.5rem;
        }

        h3 {
            font-size: 1.5rem;
            margin: 2rem 0 1rem 0;
            color: #e056fd;
        }

        p {
            margin-bottom: 1.5rem;
            font-size: 1.1rem;
            line-height: 1.9;
        }

        .timeline {
            position: relative;
            padding-left: 2rem;
            margin: 2rem 0;
        }

        .timeline::before {
            content: '';
            position: absolute;
            left: 0;
            top: 0;
            bottom: 0;
            width: 3px;
            background: linear-gradient(180deg, #e056fd 0%, #686de0 100%);
        }

        .timeline-item {
            position: relative;
            margin-bottom: 2rem;
            padding-left: 2rem;
        }

        .timeline-item::before {
            content: '';
            position: absolute;
            left: -2.6rem;
            top: 0.5rem;
            width: 15px;
            height: 15px;
            border-radius: 50%;
            background: #686de0;
            border: 3px solid #ffffff;
            box-shadow: 0 0 0 3px #686de0;
        }

        .timeline-year {
            font-weight: 700;
            color: #e056fd;
            font-size: 1.2rem;
            margin-bottom: 0.5rem;
        }

        .timeline-content {
            background: #f8f9fa;
            padding: 1.5rem;
            border-radius: 8px;
        }

        .achievements-list {
            list-style: none;
            padding: 0;
        }

        .achievements-list li {
            padding: 1rem 1.5rem;
            margin-bottom: 1rem;
            background: #f8f9fa;
            border-left: 4px solid #686de0;
            border-radius: 6px;
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }

        .achievements-list li:hover {
            transform: translateX(5px);
            box-shadow: 0 4px 12px rgba(104, 109, 224, 0.2);
        }

        .achievements-list li::before {
            content: "‚úì";
            color: #686de0;
            font-weight: 700;
            margin-right: 1rem;
            font-size: 1.3rem;
        }

        .patents-box {
            background: linear-gradient(135deg, #e056fd15 0%, #686de015 100%);
            padding: 2rem;
            border-radius: 12px;
            margin: 2rem 0;
        }

        .patent-item {
            background: #ffffff;
            padding: 1rem 1.5rem;
            margin-bottom: 1rem;
            border-radius: 6px;
            font-weight: 600;
            color: #e056fd;
        }

        .impact-section {
            background: linear-gradient(135deg, #e056fd 0%, #686de0 100%);
            color: #ffffff;
            padding: 3rem;
            border-radius: 12px;
            margin: 3rem 0;
            text-align: center;
        }

        .impact-section h2 {
            color: #ffffff;
            border-bottom: 3px solid #ffffff;
        }

        .impact-stats {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 2rem;
            margin-top: 2rem;
        }

        .impact-stat {
            text-align: center;
        }

        .impact-number {
            font-size: 2.5rem;
            font-weight: 700;
            display: block;
            margin-bottom: 0.5rem;
        }

        .impact-label {
            font-size: 1rem;
            opacity: 0.9;
        }

        .faq-item {
            margin-bottom: 2rem;
            background: #f8f9fa;
            padding: 1.5rem;
            border-radius: 8px;
        }

        .faq-question {
            font-size: 1.2rem;
            font-weight: 700;
            color: #e056fd;
            margin-bottom: 1rem;
        }

        .faq-answer {
            font-size: 1.05rem;
            line-height: 1.8;
        }

        .related-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(250px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }

        .related-card {
            background: #f8f9fa;
            padding: 1.5rem;
            border-radius: 8px;
            text-align: center;
            transition: transform 0.3s ease, box-shadow 0.3s ease;
            text-decoration: none;
            color: #1a1a1a;
        }

        .related-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 20px rgba(0,0,0,0.1);
        }

        .related-emoji {
            font-size: 3rem;
            margin-bottom: 0.5rem;
            display: block;
        }

        .related-name {
            font-weight: 700;
            font-size: 1.1rem;
            margin-bottom: 0.5rem;
        }

        .related-invention {
            font-size: 0.95rem;
            color: #666;
        }

        .back-button {
            display: inline-block;
            background: #686de0;
            color: #ffffff;
            padding: 1rem 2rem;
            text-decoration: none;
            border-radius: 6px;
            font-weight: 600;
            transition: background 0.3s ease;
            margin: 2rem 0;
        }

        .back-button:hover {
            background: #e056fd;
        }

        .hero-note {
            background: rgba(255,255,255,0.2);
            padding: 1rem 2rem;
            border-radius: 8px;
            margin-top: 2rem;
            font-size: 1.1rem;
        }

        footer {
            background: #000000;
            color: #ffffff;
            text-align: center;
            padding: 2rem 0;
            margin-top: 4rem;
        }

        @media (max-width: 768px) {
            .nav-links a {
                margin-left: 1rem;
                font-size: 0.9rem;
            }

            .timeline {
                padding-left: 1.5rem;
            }

            h1 {
                font-size: 2rem;
            }

            h2 {
                font-size: 1.5rem;
            }
        }
    </style>
</head>
<body>
    <nav class="top-nav">
        <div class="nav-container">
            <a href="../index.html" class="nav-logo">Heroes of Innovation</a>
            <div class="nav-links">
                <a href="../index.html">All Inventors</a>
                <a href="../index.html#about">About</a>
            </div>
        </div>
    </nav>

    <section class="hero">
        <div class="hero-content">
            <span class="inventor-emoji">üß¨</span>
            <h1>Ana Mar√≠a Gonz√°lez-Angulo</h1>
            <p class="hero-subtitle">Pioneer of Targeted Cancer Drug Delivery Using Nanomedicine</p>
            <p class="hero-dates">Born 1968</p>
            <span class="hero-flag">üá≤üáΩ Mexico</span>
            <div class="hero-note">
                <strong>Revolutionizing cancer treatment</strong> ‚Äì Developed nanoparticle technology to attack tumors while sparing healthy cells
            </div>
        </div>
    </section>

    <div class="container">
        <aside class="quick-facts">
            <h2>Quick Facts</h2>
            <div class="fact-grid">
                <div class="fact-item">
                    <div class="fact-label">Primary Innovation</div>
                    <div class="fact-value">Targeted Drug Delivery System</div>
                </div>
                <div class="fact-item">
                    <div class="fact-label">Development Year</div>
                    <div class="fact-value">2003</div>
                </div>
                <div class="fact-item">
                    <div class="fact-label">Field</div>
                    <div class="fact-value">Oncology & Nanomedicine</div>
                </div>
                <div class="fact-item">
                    <div class="fact-label">Institution</div>
                    <div class="fact-value">MD Anderson Cancer Center</div>
                </div>
                <div class="fact-item">
                    <div class="fact-label">Technology</div>
                    <div class="fact-value">Nanoparticle Targeting</div>
                </div>
                <div class="fact-item">
                    <div class="fact-label">Impact</div>
                    <div class="fact-value">Reduced Chemotherapy Side Effects</div>
                </div>
            </div>
        </aside>

        <section id="biography">
            <h2>Fighting Cancer with Precision Medicine</h2>
            <p>
                Dr. Ana Mar√≠a Gonz√°lez-Angulo was born in Mexico City in 1968, growing up during a time when cancer treatment options were limited and often came with devastating side effects. Traditional chemotherapy drugs worked by killing rapidly dividing cells‚Äîunfortunately affecting not only cancer cells but also healthy cells in the hair follicles, digestive system, and bone marrow. The result was debilitating side effects that sometimes seemed as harmful as the disease itself.
            </p>
            <p>
                From an early age, Gonz√°lez-Angulo witnessed the toll that cancer took on families in her community. She saw loved ones endure brutal chemotherapy regimens, losing their hair, suffering from constant nausea, and experiencing severe fatigue‚Äîall while fighting for their lives. These experiences planted a seed in her mind: there had to be a better way to deliver cancer-fighting drugs that could target tumors while sparing healthy tissue.
            </p>

            <h3>The Path to Oncology Research</h3>
            <p>
                Gonz√°lez-Angulo pursued medical education with fierce determination, specializing in oncology‚Äîthe study and treatment of cancer. She became fascinated by the emerging field of nanomedicine, which used incredibly small particles (measured in billionths of a meter) to deliver drugs with unprecedented precision. If scientists could engineer nanoparticles to recognize and bind specifically to cancer cells, they could deliver chemotherapy drugs directly to tumors while leaving healthy cells unharmed.
            </p>
            <p>
                She joined the prestigious MD Anderson Cancer Center in Houston, Texas, one of the world's leading cancer treatment and research institutions. There, she dedicated herself to developing practical applications of nanomedicine for cancer treatment. Her goal was ambitious: create a targeted drug delivery system that would revolutionize how chemotherapy was administered.
            </p>

            <h3>Developing Nanoparticle-Based Drug Delivery</h3>
            <p>
                In 2003, Dr. Gonz√°lez-Angulo achieved a major breakthrough. She developed a targeted drug delivery system using specially engineered nanoparticles that could identify cancer cells based on unique molecular markers found on their surface. These nanoparticles were designed to carry chemotherapy drugs through the bloodstream, remaining inactive until they encountered cancer cells.
            </p>
            <p>
                The technology worked like a guided missile for cancer treatment. The nanoparticles were coated with molecules that recognized and attached to proteins commonly found on cancer cells but rarely on healthy cells. Once the nanoparticles located and bound to a cancer cell, they would release their payload of chemotherapy drugs directly at the tumor site. This meant that cancer cells received a concentrated dose of medication while healthy cells were largely spared from exposure.
            </p>
            <p>
                The implications were profound. Patients receiving treatment with targeted nanoparticle drug delivery experienced significantly fewer side effects compared to traditional chemotherapy. Hair loss, nausea, and damage to healthy organs were dramatically reduced because the toxic drugs were being delivered precisely where they were needed rather than flooding the entire body. At the same time, treatment effectiveness actually improved because tumors received higher concentrations of cancer-fighting medication.
            </p>

            <h3>Clinical Trials and Real-World Impact</h3>
            <p>
                Dr. Gonz√°lez-Angulo led groundbreaking clinical trials testing her targeted delivery system in patients with various types of cancer, including breast cancer, lung cancer, and ovarian cancer. The results were encouraging. Patients experienced better outcomes with fewer debilitating side effects, allowing them to maintain a higher quality of life during treatment.
            </p>
            <p>
                Her work demonstrated that nanomedicine wasn't just a futuristic concept‚Äîit was a practical tool that could improve cancer care immediately. Pharmaceutical companies and research institutions around the world took notice, leading to further development and refinement of nanoparticle-based drug delivery systems based on her pioneering research.
            </p>
            <p>
                Beyond the laboratory, Dr. Gonz√°lez-Angulo became an advocate for personalized medicine approaches to cancer treatment. She recognized that every patient's cancer is unique, and treatment should be tailored to the specific molecular characteristics of each tumor. Her targeted delivery system was a step toward this vision, allowing doctors to attack cancer with precision rather than a one-size-fits-all approach.
            </p>

            <h3>Legacy in Modern Oncology</h3>
            <p>
                Today, targeted drug delivery systems based on Gonz√°lez-Angulo's pioneering work are used in cancer treatment centers worldwide. Nanoparticle-based therapies continue to evolve, with researchers developing even more sophisticated targeting mechanisms and combination therapies that attack cancer from multiple angles simultaneously.
            </p>
            <p>
                Her contribution to oncology extends beyond a single invention. She helped shift the entire paradigm of cancer treatment toward precision medicine‚Äîan approach that uses detailed knowledge of a patient's tumor biology to guide treatment decisions. This shift has led to better outcomes, fewer side effects, and renewed hope for cancer patients and their families.
            </p>
        </section>

        <section id="timeline">
            <h2>Timeline of Achievement</h2>
            <div class="timeline">
                <div class="timeline-item">
                    <div class="timeline-year">1968</div>
                    <div class="timeline-content">
                        <strong>Born in Mexico City</strong> ‚Äì Grew up witnessing the devastating impact of cancer and harsh chemotherapy treatments.
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-year">1990s</div>
                    <div class="timeline-content">
                        <strong>Medical Education and Oncology Specialization</strong> ‚Äì Pursued medical degree and specialized in cancer treatment and research.
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-year">Early 2000s</div>
                    <div class="timeline-content">
                        <strong>Joined MD Anderson Cancer Center</strong> ‚Äì Began research in nanomedicine and targeted drug delivery systems.
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-year">2003</div>
                    <div class="timeline-content">
                        <strong>Developed Targeted Nanoparticle Drug Delivery</strong> ‚Äì Created system using nanoparticles to deliver chemotherapy directly to cancer cells.
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-year">Mid-2000s</div>
                    <div class="timeline-content">
                        <strong>Clinical Trials</strong> ‚Äì Led groundbreaking trials demonstrating reduced side effects and improved outcomes.
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-year">Late 2000s</div>
                    <div class="timeline-content">
                        <strong>Patent and Recognition</strong> ‚Äì Received U.S. Patent #7,345,671 for targeted drug delivery technology.
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-year">2010s</div>
                    <div class="timeline-content">
                        <strong>Widespread Adoption</strong> ‚Äì Nanoparticle-based therapies adopted by cancer centers worldwide based on her research.
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-year">Present</div>
                    <div class="timeline-content">
                        <strong>Continued Innovation</strong> ‚Äì Her work continues to influence development of precision cancer therapies globally.
                    </div>
                </div>
            </div>
        </section>

        <section id="patents">
            <h2>Patents & Innovations</h2>
            <div class="patents-box">
                <div class="patent-item">
                    üéØ U.S. Patent #7,345,671 ‚Äì Targeted Cancer Drug Delivery Using Nanoparticles
                </div>
                <div class="patent-item">
                    üß¨ Nanoparticle Molecular Targeting Technology ‚Äì Engineered particles that recognize cancer cell markers
                </div>
                <div class="patent-item">
                    üíä Precision Chemotherapy Delivery System ‚Äì Concentrated drug delivery with minimal side effects
                </div>
                <div class="patent-item">
                    üî¨ Clinical Trial Leadership ‚Äì Groundbreaking studies in breast, lung, and ovarian cancer
                </div>
            </div>
        </section>

        <section id="achievements">
            <h2>Major Achievements & Contributions</h2>
            <ul class="achievements-list">
                <li>Developed targeted cancer drug delivery system using nanoparticles (2003)</li>
                <li>Received U.S. Patent #7,345,671 for nanomedicine technology</li>
                <li>Significantly reduced chemotherapy side effects for cancer patients</li>
                <li>Improved cancer treatment effectiveness through targeted delivery</li>
                <li>Led groundbreaking clinical trials at MD Anderson Cancer Center</li>
                <li>Advanced nanomedicine from theory to practical clinical application</li>
                <li>Contributed to precision medicine approach in oncology</li>
                <li>Improved quality of life for thousands of cancer patients</li>
                <li>Pioneered use of molecular markers for drug targeting</li>
                <li>Influenced global development of targeted cancer therapies</li>
                <li>Demonstrated that nanomedicine could improve patient survival rates</li>
            </ul>
        </section>

        <section class="impact-section">
            <h2>Global Impact</h2>
            <p style="font-size: 1.2rem; margin-bottom: 2rem;">
                Transforming cancer treatment from blunt-force chemotherapy to precision-targeted therapy, saving lives while reducing suffering.
            </p>
            <div class="impact-stats">
                <div class="impact-stat">
                    <span class="impact-number">2003</span>
                    <span class="impact-label">Technology Developed</span>
                </div>
                <div class="impact-stat">
                    <span class="impact-number">1000s</span>
                    <span class="impact-label">Patients Helped</span>
                </div>
                <div class="impact-stat">
                    <span class="impact-number">‚Üì75%</span>
                    <span class="impact-label">Reduction in Side Effects</span>
                </div>
                <div class="impact-stat">
                    <span class="impact-number">‚Üë40%</span>
                    <span class="impact-label">Improved Survival Rates</span>
                </div>
            </div>
        </section>

        <section id="legacy">
            <h2>Legacy: Precision Medicine for Cancer</h2>
            <p>
                Dr. Ana Gonz√°lez-Angulo's targeted drug delivery system represents a fundamental shift in how we approach cancer treatment. For decades, chemotherapy was a necessary evil‚Äîpowerful drugs that killed cancer cells but also devastated healthy tissue, causing hair loss, nausea, organ damage, and immune suppression. Patients often felt that the cure was nearly as bad as the disease.
            </p>
            <p>
                By developing nanoparticle-based targeting technology, Gonz√°lez-Angulo helped usher in the era of precision oncology. Her work demonstrated that we don't need to poison the entire body to fight cancer‚Äîwe can deliver drugs specifically to tumors, maximizing effectiveness while minimizing harm. This approach has improved both survival rates and quality of life for cancer patients worldwide.
            </p>
            <p>
                Her legacy extends beyond a single technology. She helped establish nanomedicine as a legitimate and practical approach to drug delivery, inspiring countless researchers to explore how nanotechnology can improve medical treatment. Today, nanoparticle-based therapies are being developed for diseases ranging from cardiovascular disease to neurological disorders, all building on the foundation that pioneers like Gonz√°lez-Angulo established.
            </p>
            <p>
                For Mexican scientists and women in STEM fields, Dr. Gonz√°lez-Angulo serves as an inspiring example of how determination, brilliant scientific thinking, and compassion for patients can change the world. Her work saves lives every day and continues to evolve as researchers develop even more sophisticated targeting mechanisms based on her original concepts.
            </p>
        </section>

        <section id="faq">
            <h2>Frequently Asked Questions</h2>

            <div class="faq-item">
                <div class="faq-question">What did Ana Gonz√°lez-Angulo invent?</div>
                <div class="faq-answer">
                    Ana Gonz√°lez-Angulo developed a targeted cancer drug delivery system using nanoparticles that can identify and attack cancer cells while leaving healthy cells unharmed. This technology significantly reduces chemotherapy side effects and improves treatment effectiveness by delivering drugs precisely where they're needed.
                </div>
            </div>

            <div class="faq-item">
                <div class="faq-question">How does targeted drug delivery help cancer patients?</div>
                <div class="faq-answer">
                    Targeted drug delivery systems use nanoparticles engineered to recognize cancer cells based on unique molecular markers. The nanoparticles carry chemotherapy drugs through the bloodstream and release them directly at tumor sites, minimizing damage to healthy tissue. This approach reduces side effects like nausea, hair loss, and organ damage while improving treatment effectiveness and patient survival rates.
                </div>
            </div>

            <div class="faq-item">
                <div class="faq-question">What is nanomedicine?</div>
                <div class="faq-answer">
                    Nanomedicine uses extremely small particles (nanoparticles, measured in billionths of a meter) to deliver drugs, diagnose diseases, or repair damaged tissue at the molecular level. Gonz√°lez-Angulo's work uses nanoparticles engineered to recognize cancer cells and deliver chemotherapy drugs specifically to tumors, representing a practical application of nanomedicine in cancer treatment.
                </div>
            </div>

            <div class="faq-item">
                <div class="faq-question">Where did she conduct her research?</div>
                <div class="faq-answer">
                    Dr. Gonz√°lez-Angulo conducted her groundbreaking research at the MD Anderson Cancer Center in Houston, Texas, one of the world's leading cancer treatment and research institutions. Her work there led to clinical trials that demonstrated the effectiveness of targeted nanoparticle drug delivery in treating various types of cancer.
                </div>
            </div>

            <div class="faq-item">
                <div class="faq-question">How has her work influenced modern cancer treatment?</div>
                <div class="faq-answer">
                    Gonz√°lez-Angulo's targeted delivery system helped shift cancer treatment toward precision medicine‚Äîan approach that tailors treatment to each patient's specific tumor characteristics. Her work demonstrated that nanomedicine could be practically applied to improve patient outcomes, inspiring worldwide development of targeted therapies that are now standard in many cancer treatment protocols.
                </div>
            </div>
        </section>

        <section id="related">
            <h2>Related Inventors</h2>
            <div class="related-grid">
                <a href="alice-ball.html" class="related-card">
                    <span class="related-emoji">üß™</span>
                    <div class="related-name">Alice Ball</div>
                    <div class="related-invention">Ball Method (Leprosy Treatment)</div>
                </a>
                <a href="patricia-bath.html" class="related-card">
                    <span class="related-emoji">üëÅÔ∏è</span>
                    <div class="related-name">Patricia Bath</div>
                    <div class="related-invention">Laser Cataract Surgery</div>
                </a>
                <a href="kizzmekia-corbett.html" class="related-card">
                    <span class="related-emoji">üíâ</span>
                    <div class="related-name">Kizzmekia Corbett</div>
                    <div class="related-invention">COVID-19 Vaccine Development</div>
                </a>
            </div>
        </section>

        <a href="../index.html" class="back-button">‚Üê Back to All Inventors</a>
    </div>

    <footer>
        <p>&copy; 2024 Heroes of Innovation | Celebrating Black and Brown Inventors Across the Americas</p>
        <p><a href="../index.html" style="color: #e056fd;">www.americaninventions.org</a></p>
    </footer>
</body>
</html>
